News Focus
News Focus
Followers 35
Posts 2237
Boards Moderated 0
Alias Born 10/18/2019

Re: manibiotech post# 693927

Saturday, 05/25/2024 11:43:16 AM

Saturday, May 25, 2024 11:43:16 AM

Post# of 822496
Manibiotec, yes I agree, l looked at 1 Mont, 3 month, ytd, 6 month, one year, and 3 year chart and yesterday posted that all are down. The 4 and 5 year charts show gains but in this stock I go back to 2015 and is not a nice chart. It was my decision but many years back I sold another stock to purchase more nwbo and that other stock went well over $100 a share and nwbo (at least to now) is a very far cry from 100+ a share. I have talked utmost respect for the researchers but took me a long time to take what I hear from nwbo with a grain of salt. I used to speak with Les Goldman at least every month and I do like the guy but imo they lack the experience to move forward in a timely manner. I have often thought they should add a person with such experience to the management team. They have a good product (imo) but certainly has been a struggle to get it to market. Dilution in such companies is expected but when I started the outstanding shares were less than 100 million and now a bit higher than that - like 10 to 15 times. Imo the statement from LP that all big pjarma brings is a checkbook, well they needed that checkbook. I still think they should get approval in UK but the real potential revenue comes with fda approval and as the vaccine is at least as good as temozolomide (part of soc) imo should also be able to get US approval. Both temozolomide and dcvax add at median about 3 months to os and dcvax has the long tail survivors. Partner up and get this thing out there
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News